Seeking Alpha

Art2004

Art2004
Send Message
View as an RSS Feed
View Art2004's Comments BY TICKER:
Latest  |  Highest rated
  • Advanced Cell Technology: All Systems Go [View article]
    The cutting edge, to be at the forefront of regenerative medicine, the advanced research and knowledge of stem cells and tissue engineering, to change the face of modern medicine, the Lancet article, all the patents, the scientific reputation of ACT. the ability to attract top doctors and hospitals for clinical trials, the product pipeline, the RAISON D'ETRE for ACT is Dr. Robert Lanza. Allow yourself to be enlightened and read some biographical and scientific information about the good Doctor.
    Nov 11, 2014. 05:21 PM | 3 Likes Like |Link to Comment
  • Advanced Cell Technology Is Severely Undervalued [View article]
    A good, well written and logical article. The article is present -future oriented. The author does not attempt to dredge up every bone in ACTC's past closet. Hopefully when ACT gets upllisted to the NASDAQ before the end of 2014, this is how professional analysts will approach the stock. The author notes the efficacy and safety data presented in the Lancet article which were both quite postive. He then analyzes the potential market of AMD patients world wide and ends up with a small percentage who can afford the treatment. But even at 4% of the total, the author projects ACT's revenue three years after commercialization to be in the billions of dollars. Well, read over the article for the details.
    Nov 7, 2014. 06:01 PM | 6 Likes Like |Link to Comment
  • Advanced Cell Technology Is Scaling Up Its Blood Program [View article]
    http://bit.ly/1EdaUWj

    Doug, the link to Dr. Lanza's recent article on blood platelets.
    Nov 3, 2014. 10:51 AM | Likes Like |Link to Comment
  • Advanced Cell Technology Is Scaling Up Its Blood Program [View article]
    According to Dr. Robert Lanza's most recent blood platelet article and patent, ACT does have platelets that meet all of the DOD's contract requirements. Have to see if ACTdoes receive an award from the DOD.
    Nov 3, 2014. 10:46 AM | Likes Like |Link to Comment
  • Advanced Cell Technology Is Scaling Up Its Blood Program [View article]
    Great article! With ACTC embarking on a road show with Jeffries hoping for a follow up announcement before the ASM on Nov 12.
    Oct 27, 2014. 10:30 AM | 1 Like Like |Link to Comment
  • Advanced Cell Technology Has Groundbreaking Results [View article]
    Another excellent article on ACTC BIOcell. Too bad Eskella got his article published earlier. Hopefully, there will be other progress updates from ACT where your more objective reporting and quotes from experts can be presented in SA.
    Oct 19, 2014. 09:51 AM | Likes Like |Link to Comment
  • Update: Advanced Cell Technology Interim Results And Shelf Offerings [View article]
    Eskela, if you were following ACT closely, you would know that they believe that partnership offers after phase2 research would be billions of dollars higher than after phase 1. Would you agree that ACT has enough funds to conduct phase 2 research?
    Oct 15, 2014. 11:18 AM | 6 Likes Like |Link to Comment
  • Update: Advanced Cell Technology Interim Results And Shelf Offerings [View article]
    Eskela, I read this as a dishonest article. To what do you attribute the improvements
    in vision of over 2/3 of the patients? The eye photos show engraftment, Oh wise person, what is your medical reason and qualifications for not attributing visual improvements to the RPE cells? Did you ever read Dr. Lanza's rather complete explanations of how injected RPE's can benefit photoreceptors in the eye. Are you more qualified in vision research than Dr. Lanza and Dr. Schwartz. IMHO You are a fraud.

    Re:big pharma, they have made partnership offers to ACT, but the offers according to ACT have been too low.
    Oct 15, 2014. 10:20 AM | 13 Likes Like |Link to Comment
  • A Repudiation Of Advanced Cell Technology's 'Whisper' Results [View article]
    Were cataract patients excluded from the research or not? If excluded your arguments are irrelevant. I do know the screenings and the exclusions affected a majority of patient pool. For you to attempt to invalidate the results of the study before publication may be irresponsible.
    Sep 22, 2014. 01:54 PM | Likes Like |Link to Comment
  • Advanced Cell Technology: Time To Buy The Rumor (Again) [View article]
    Article had slightly old news, author could have noted that engraftment of RPE cells is consistent and improvements in visual function appear to be continuing over time.
    Just yesterday GE announced that the HQ of its Life Sciences Division will be located in a new facility devoted to stem cell research in Marlborough, Mass home of ACT. Investors are speculating that some sort of partnership will be announced. As ACT expands, it is thought that GE could handle ACT's cell production in new, automated bioreacters. So here are new rumors to buy ACTC on. lol
    Aug 21, 2014. 10:44 AM | 6 Likes Like |Link to Comment
  • Advanced Cell Technology's Intellectual Property Takes A Hit [View article]
    Look for medical/science journal article in about 3-4 months.

    ACT-Lanza working on many other projects: MCPs and dog studies with Tufts
    Apr 13, 2014. 03:45 PM | Likes Like |Link to Comment
  • New Mesenchymal Stem Cell Population from Human Pluripotent Stem Cells Displays Potent Immunomodulatory and Therapeutic Properties [View article]
    Trust in God and Dr. Lanza (ACT)
    Mar 25, 2014. 04:24 PM | Likes Like |Link to Comment
  • Advanced Cell Technology's Intellectual Property Takes A Hit [View article]
    Why don't you name your source and his experience?

    Why don't you name the prestigous eye hospitals conducting the research for ACT?

    Why don't you do a quick financial summary of the dollars to be earned by applying ACT's cell procedures to stopping and reversing AMD?. It's in the billions of dollars.
    Feb 18, 2014. 08:37 AM | Likes Like |Link to Comment
  • Can We Predict a Corporate Bankruptcy? [View article]
    Someone just posted on an ICell message board that Audit Integrity has just dropped coverage of ACTC. Any rationale?
    Feb 18, 2014. 08:16 AM | Likes Like |Link to Comment
  • Advanced Cell Technology's Intellectual Property Takes A Hit [View article]
    Why don't you comment on Dr, Lanza's research which demonstrated that hESC's are thousands of times more powerful than stem cells derived from adult cells.

    By the time your stem cell research experiment finds its way to human clinical applications, ACT will be an established company with approved clinical applications and a market cap in the billions.

    How do you jump from a mice experiment to ACT's patent portfolio? If companies want the gold standard, they will license from ACT.

    Sorry, but like others I find your article as a hatchet job.
    Feb 12, 2014. 04:07 PM | 6 Likes Like |Link to Comment
COMMENTS STATS
30 Comments
69 Likes